SALUBRISBIO

Serial Number 99177965
686

Registration Progress

Application Filed
May 9, 2025
Under Examination
Approved for Publication
Oct 28, 2025
Published for Opposition
Oct 28, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Nov 27, 2025 17 days

Trademark Image

SALUBRISBIO

Basic Information

Serial Number
99177965
Filing Date
May 9, 2025
Published for Opposition
October 28, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
686
Status Date
Oct 28, 2025
Application
Pending
Classes
005

Rights Holder

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

99
Address
Zone A, 4F, 289 Digitland,
2 Hongliu Road, Futian District,
Shenzhen, Guangdong 518000
CN

Ownership History

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

Original Applicant
99
Shenzhen, Guangdong CN

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

Owner at Publication
99
Shenzhen, Guangdong CN

Legal Representation

Attorney
Kayleigh A. Hartwig

USPTO Deadlines

Next Deadline
17 days remaining
Published for Opposition
Due Date
November 27, 2025
Extension Available
Until December 27, 2025

Application History

12 events
Date Code Type Description Documents
Oct 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 29, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 29, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 29, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 29, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 29, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 24, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 19, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 9, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 9, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-diabetic pharmaceuticals; Injectable dermal filler; Enzymes for medical purposes; Insulin; Vaccines for human use; Diagnostic preparations for medical purposes; Dietetic foods adapted for medical use; Pharmaceutical preparations, namely, elixirs for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biological preparations for the treatment of cardiovascular and cerebrovascular system, hematologic disorders, dermatological diseases, ophthalmic diseases, and gastrointestinal diseases, infectious diseases, cancers, nervous system diseases, diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and hypersensitivity diseases; Biologics in the nature of cells for medical use

Additional Information

Pseudo Mark
SALUBRIS BIO

Classification

International Classes
005